بررسی اثرات محافظتی دفریپرون در کاهش عوارض قلبی دوکسوروبیسین در مدل رت

Assessment of Cardio protective Effect of Deferiprone on Doxorubicin-Induced Cardiac Toxicity in a Rat Model


چاپ صفحه
پژوهان
صفحه نخست سامانه
نویسندگان
نویسندگان
اطلاعات تفضیلی
اطلاعات تفضیلی
دانلود مقاله
دانلود مقاله
دانشگاه علوم پزشکی تبریز
دانشگاه علوم پزشکی تبریز

نویسندگان: صبا غفاری , صدف کلهری , حسین بابائی , یدالله آذرمی

عنوان کنگره / همایش: 21st International Conference on Cancer and Clinical Oncology 21st International Conference on Cancer and Clinical Oncology , Turkey , istanbul , 2019

اطلاعات کلی مقاله
hide/show

نویسنده ثبت کننده مقاله صدف کلهری
مرحله جاری مقاله تایید نهایی
دانشکده/مرکز مربوطه مرکز تحقیقات کاربردی دارویی
کد مقاله 70602
عنوان فارسی مقاله بررسی اثرات محافظتی دفریپرون در کاهش عوارض قلبی دوکسوروبیسین در مدل رت
عنوان لاتین مقاله Assessment of Cardio protective Effect of Deferiprone on Doxorubicin-Induced Cardiac Toxicity in a Rat Model
نوع ارائه سخنرانی
عنوان کنگره / همایش 21st International Conference on Cancer and Clinical Oncology 21st International Conference on Cancer and Clinical Oncology
نوع کنگره / همایش بین المللی
کشور محل برگزاری کنگره/ همایش Turkey
شهر محل برگزاری کنگره/ همایش istanbul
سال انتشار/ ارائه شمسی 1398
سال انتشار/ارائه میلادی 2019
تاریخ شمسی شروع و خاتمه کنگره/همایش 1398/09/28 الی 1398/09/29
آدرس لینک مقاله/ همایش در شبکه اینترنت https://panel.waset.org/conference/2019/12/istanbul/ICCCO
آدرس علمی (Affiliation) نویسنده متقاضی دانشگاه علوم پزشکی تبریز-مرکز تحقیقات کاربردی دارویی

نویسندگان
hide/show

نویسنده نفر چندم مقاله
صبا غفاریسوم
صدف کلهریاول
حسین بابائیدوم
یدالله آذرمیچهارم

اطلاعات تفضیلی
hide/show

عنوان متن
خلاصه مقالهAbstract Introduction: Doxorubicin (DOX)-induced cardiotoxicity is widely-known as the most severe complications of anthracycline based chemotherapy in patients with cancer. It is unknown whether Deferiprone(DFP), could reduce the severity of DOX-induced cardiotoxicity by inhibiting free radical reactions. Thus, this study was performed to assess the protective effect of Deferiprone on DOX-induced cardiotoxicity in a rat model. Methods: The rats were divided into five groups. Group one was control group. Group 2 was DOX (2 mg/kg/day, every other day for 12 days), and Group three to five which receiving DOX as in group 2 and DFP 75,100 and 150 mg/kg/day, for 19 days, respectively. DFP was starting 5 days prior to first DOX injection and two days after the last DOX injection throughout the study. Electrocardiographic and hemodynamic studies, along with histopathological examination were conducted. In addition, serum sample was taken and total cholesterol,Malone dialdehyde,triglyceride,albumin,AST,ALT,total protein,lactate dehydrogenase,total anti-oxidant and creatine kinase were assessed. Result: Our results showed normal structure of endocard, myocard and pericard in control group. Pathologic data such as edema, hyperemia, bleeding, endocarditis, myocarditis and pericarditis, hyaline degeneration, cardiomyocyte necrosis, myofilament degeneration and nuclear chromatin changes were assessed in all groups. In DOX group, all pathologic data was seen with mean grade of 2±1.25. In DFP group with a dose of 75 and 100 mg the mean grade were 1.41± 0.31 and 1±.23, respectively. In DFP group with a dose of 150, the pathologic data showed a milderchanges in compare with other groups with e mean grade of 0.45 ±0.19. Most pathologic data in DFP groups showed significant changes in compare with DOX group (p<0.001). Discussion: The results also showed that DFP treatment significantly improved DOX-induced heart damage, structural changes in the myocardium and ventricular function. Our data confirm that DFP is protective against cardiovascular-related disorders induced by DOX. Clinical studies are needed to be involved to examine these findings in human.
کلمات کلیدیKeywords: Doxorubicine, deferiprone, cardiomyopathy, Rat

لینک دانلود مقاله
hide/show

نام فایل تاریخ درج فایل اندازه فایل دانلود
invitation.pdf1398/10/08132703دانلود
Abstract.docx1398/10/0816213دانلود
certificates.pdf1398/10/08417790دانلود
best-presentation-award[2028].pdf1398/10/08388032دانلود
ticket_1012494641.pdf1398/10/08307746دانلود
ticket.png1398/10/0868495دانلود
1.jpg1398/10/09526033دانلود
2.jpg1398/10/09399869دانلود
Assessment_of_Cardioprotective_Effect_of_Deferiprone_on_Doxo.pdf1398/10/23136293دانلود